- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
NCOA4 Antibody(Ascites)Mouse Monoclonal Antibody (Mab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AM2019a | 0.1 ml 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
NCOA4 Antibody(Ascites) - Product info | |
| Application | WB
|
| Primary Accession | Q13772 |
| Other Accession | NP_001138734.1, NP_001138732.1 |
| Reactivity | Human |
| Concentration | Crude ascites |
| Isotype | IgM |
| Clone Names | 439CT10.4.4 |
| Calculated MW | 69726 Da |
NCOA4 Antibody(Ascites) - Additional info | |
| Gene ID 8031 | |
| Other Names NCOA4; ARA70; ELE1; RFG; Nuclear receptor coactivator 4; Androgen receptor coactivator 70 kDa protein; Androgen receptor-associated protein of 70 kDa; Ret-activating protein ELE1 | |
| Target/Specificity Purified His-tagged NCOA4 protein(Fragment) was used to produced this monoclonal antibody. | |
| Dilution WB~~1:500~3200 | |
| Format Mouse monoclonal antibody supplied in crude ascites with 0.09% (W/V) sodium azide. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions NCOA4 Antibody(Ascites) is for research use only and not for use in diagnostic or therapeutic procedures. | |
NCOA4 Antibody(Ascites) - Protein Information | |
| Name NCOA4 | |
| Synonyms ARA70, ELE1, RFG | |
| Function Enhances the androgen receptor transcriptional activity in prostate cancer cells. Ligand-independent coactivator of the peroxisome proliferator-activated receptor (PPAR) gamma | |
| Tissue Location Widely expressed. Also detected in adipose tissues and in different cell lines. Isoform Beta is only expressed in testis | |
NCOA4 Antibody(Ascites) - Related products
AM2019a: NCOA4 Antibody(Ascites)
AP16218b: NCOA4 Antibody (C-term)
RI13513: NCOA4 predesign siRNA
DC03481: Human NCOA4 cDNA Clone
AT2981a: NCOA4 Antibody (monoclonal) (M01)
NCOA4 Antibody(Ascites) - Application data
-
NCOA4 Antibody (Cat. #AM2019a) western blot analysis in 293 cell line lysates (35ug/lane).This demonstrates the NCOA4 antibody detected the NCOA4 protein (arrow).
NCOA4 Antibody(Ascites) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes an androgen receptor coactivator. The encoded protein interacts with the androgen receptor in a ligand-dependent manner to enhance its transcriptional activity. Chromosomal translocations between this gene and the ret tyrosine kinase gene, also located on chromosome 10, have been associated with papillary thyroid carcinoma. Alternatively spliced transcript variants have been described. Pseudogenes are present on chromosomes 4, 5, 10, and 14.
REFERENCES
Sadow, P.M., et al. Endocr. Pathol. 21(2):73-79(2010) Landa, I., et al. PLoS Genet. 5 (9), E1000637 (2009) : Richardson, D.S., et al. Cancer Res. 69(11):4861-4869(2009) Peng, Y., et al. Am. J. Pathol. 172(1):225-235(2008) Bongarzone, I., et al. Genomics 42(2):252-259(1997)
